McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Ms. Lori A. Schechter J.D.

Board & Enterprise Risk Advisor

Mr. Brian S. Tyler Ph.D.

Chief Executive Officer & Director

Ms. LeAnn B. Smith

Executive Vice President & Chief Human Resources Officer

Mr. Napoleon B. Rutledge Jr.

Senior Vice President, Controller & Chief Accounting Officer

Mr. Britt J. Vitalone

Executive Vice President & Chief Financial Officer

Mr. Francisco  Fraga

Executive Vice President, Chief Information Officer & Chief Technology Officer

Rachel  Rodriguez

Vice President of Investor Relations

Ms. Michele  Lau

Executive Vice President & Chief Legal Officer

Mr. Pete  Slone

Senior Vice President of Corporate Public Affairs

Mr. Kirk  Kaminsky

President of The US Pharmaceutical & Specialty Solutions Business

Názov	Trhová kapitalizácia
Itonis, Inc.	0M
Patterson Companies, Inc.	0M
MediPal Holdings Corporation	0M
Owens & Minor, Inc.	0M
Yamashita Health Care Holdings,Inc.	0M
Uniphar plc	0M
PT Enseval Putera Megatrading Tbk.	0M
Shanghai Pharmaceuticals Holding Co., Ltd	0M
Synergy CHC Corp.	0M
EBOS Group Limited	0M
Medlive Technology Co., Ltd.	0M

McKesson Corporation

McKesson Corporation Zoznam konkurentov

Hlavní konkurenti